Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

BioGaia

110.50 SEK

+0.64 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioGaia

2019202020212022202320242025
Revenue768.3747.1785.11,104.01,296.51,422.71,538.2
growth-%-2.8 %5.1 %40.6 %17.4 %9.7 %8.1 %
EBITDA258.1248.7281.0385.4468.4500.1437.2
EBIT242.5228.2253.7361.5443.1423.4412.5
Profit before taxes242.3227.6252.7447.6468.8447.8421.2
Net income187.3179.7196.3373.6365.4351.4332.8
EPS2.162.011.943.703.623.483.29
Dividend0.750.680.732.906.906.904.00
Dividend ratio34.7 %33.9 %37.4 %78.4 %190.6 %198.3 %121.6 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%33.6 %33.3 %35.8 %34.9 %36.1 %35.1 %28.4 %
EBIT-%31.6 %30.5 %32.3 %32.7 %34.2 %29.8 %26.8 %
ROE36.9 %10.3 %10.5 %18.9 %18.0 %20.4 %25.3 %
ROI28.1 %9.4 %9.2 %16.9 %15.7 %17.3 %20.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.